Eloxx Pharmaceuticals raises $50m on Nasdaq
News| Globes The company is developing a drug for treatment of cystic fibrosis. Eloxx Pharmaceuticals, which develops drugs for rare genetic diseases, announced that it has raised $50 million at…
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery
Multinational study expected to include clinical sites in U.S. Israel and Europe, where study has been awarded an $8.7 million grant from European Horizon 2020 Program April 25, 2018 07:00 ET | Source: Pluristem…
The Rise of #Nanomedicine
APRIL 18, 2018 | Research | NanoMagazine Medicine has been around for thousands of years, but as always, medicine is changing. Throughout the years, humans have switched from apothecary to packing active…
CytoReason uses AI to personalize #drugs, opening the door to #cancer treatments
STEWART ROGERS | APRIL 16, 2018 8:30 AM The first question most people have when talking about #artificialIntelligence is if it will help us or harm us. But in the health…
Spotlight On Israel: Market Challenges Stunting Biopharma Growth
23 Apr 2018 | Lucie Ellis Executive Summary Scrip investigates the big issues Israel's #biopharma sector need to overcome in order to maintain momentum and achieve sustainable success. In its…
(Personalized medicine is approaching a major breakthrough” (Hebrew”
"הרפואה המותאמת אישית מתקרבת לפריצת דרך משמעותית" פרופ' דיוויד סידרנסקי, חוקר סרטן נודע בארה"ב ומנהל קרן השקעות הביומד בישראל (IBF), מסביר בראיון ל"גלובס" מדוע רק עכשיו הרפואה המותאמת אישית עומדת…
Healthy.io Brings Smartphone Urine Tests to U.S. Homes
The Israel-based startup partnered with the American National Kidney Foundation and Pennsylvania-based Geisinger Health System to offer its testing kits to U.S. patients Lilach Baumer | 19:26 15.04.18 The American National Kidney…
Mylan buys rights to Israel-developed Multiple Sclerosis treatment
MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week By TOI STAFF 11 April 2018, 12:19 am | Times New Israel Mylan already sells a generic…
Medtronic Buys Medical Visualization Company Visionsense for $65 Million
The medical device developer intends to integrate Israel-based Visionsense's operations into its own activities Meir Orbach | 10:16 10.04.18 | Calcalistech Medical device maker Medtronic PLC is buying Israel-based medical visualization company…
Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing
EMERGING ISRAELI BIOPHARMA FLIES FLAG FOR EX-BMS CANCER THERAPY by Phil Taylor | Apr 10, 2018 9:57am | FierceBiotech Israeli biotech Ayala Pharmaceuticals, founded last year as a development vehicle for two…